2025-11-13T19:44:28-05:00 2024-12-31 990 2024-01-01 270425749 PREVENT ALZHEIMERS DISEASE 2020 INC PREV 3013096730 9812 FALLS ROAD SUITE 114 155 Potomac MD 20854 ARA KHACHATURIAN Executive Vice President and Treas 3013096730 2025-11-14 2024 2025-03-06 01:10:19Z ARA KHACHATURIAN 9812 FALLS RD STE 114 155 POTOMAC MD 20854 442190 false X WWW.PAD2020.ORG X 2009 MD PAD2020 aims to unite the nation towards increasing research and knowledge to prevent Alzheimers disease and other neurodegenerative diseases that affect memory movement or mood. 4 4 0 80 0 0 357136 442190 0 0 0 0 0 0 357136 442190 0 0 0 0 0 0 0 0 0 471717 425745 471717 425745 -114581 16445 1214 17659 0 0 1214 17659 PAD2020 was created to rally national support and focus on increasing research and knowledge to prevent Alzheimers disease and other neurodegenerative diseases that affect the memory movement or mood of individuals. false false 225447 265314 0 In the United States two major regulatory hurdles must be overcome for affordable and accessible tools to be developed and deployed for diagnosing assessing and monitoring those at risk of or with cognitive disorders. The FDA and CMS have two different regulatory missions. Developers of new clinical interventions and tools must demonstrate the effectiveness and clinical relevance of their outcomes. They also need to consider factors such as reimbursement and quality. To address these challenges the Campaign to Prevent Alzheimers Disease launched a task force to review recommendations and develop new project proposals. The group titled The Campaign to Prevent Alzheimers Disease Work Group on Community-Based Detection and Assessment of Cognitive Decline, identified different pathways of community-based detection using electronic health records from different international healthcare systems to detect and monitor individuals with early cognitive impairment. The recommendations aim to guide future sustainability activities public policy campaigns and implementation pilots. 41514 65000 0 Alzheimers disease poses a significant burden on a global scale which has led to an enormous investment in research to find a cure. However despite these efforts there are very few medications available for people with dementia. The search for new interventions for Alzheimers disease is challenging because the exact relationship between the symptoms of the disease and its neurobiology is not yet fully understood. The diseases heterogeneity complex biological and environmental interactions multiple nonlinear timescales and a lack of modeling systems to integrate complex relationships further complicate this effort. To address these challenges the Calcium System Theory of Alzheimers Disease CAST-AD workgroup aims to design a unified systems theory. The group aims to create new foundational models to study protein dynamics and aggregation in neurodegenerative diseases. These models will be trained using supercomputing and hybrid super- and quantum-computing to simulate large data sets of proteins. The project will establish and validate foundational models using proteins such as bioluminescent enzymes to provide an easy functional readout. The group will then apply these models to crucial proteins and peptides involved in neurodegenerative diseases. 49061 70000 0 Brain vascular diseases are linked to the onset of dementia. PAD 20 20 coordinated a global task force to assess the efficacy of utilizing approved vascular health interventions to prevent or treat dementia. Evidence shows that modifying lifestyle factors such as physical activity healthy diet and proper sodium intake can improve vascular health and offer an opportunity for brain health. The initiative aims to identify tangible opportunities to provide financial or technical resources to sustain multi-year activities and evaluate approaches that may accelerate the development of new interventions. The project will focus on developing strategies to provide affordable accessible and equitable dementia prevention through widely prescribed medications for various vascular and metabolic disorders. There is a clear need for robust clinical evidence to support this public health approach. 0 0 0 316022 true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false 0 0 true 0 false false false false false false false 0 false false false false false false false false false false 4 4 true false false false false false false true true false false false true true true true true false false false MD ARA KHACHATURIAN 3013096730 9812 Falls Road Suite 114 155 POTOMAC MD 20854 ZAVEN KHACHATURIAN CHAIR PRESIDENT 20.00 0.00 X X 0 0 0 ARA KHACHATURIAN EVP TREASURER 20.00 0.00 X X 0 0 0 PETER SNYDER DIRECTOR 1.00 0.00 X 0 0 0 KATE HAYDEN DIRECTOR 1.00 0.00 X 0 0 0 0 0 0 0 false false false 0 0 0 0 0 442190 0 442190 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 442190 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 140037 121378 18659 0 20543 0 0 0 18720 0 0 0 0 0 0 0 0 0 0 0 0 0 3244 0 0 0 0 0 0 0 32471 32471 0 0 9740 9740 0 0 91877 91877 0 0 38233 38233 0 0 22323 22323 0 0 0 0 0 0 26501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16755 0 0 0 Subscriptions 3540 0 0 0 Printing 1761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 425745 316022 18659 0 0 0 0 0 1214 17659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1214 17659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 0 1214 17659 1214 17659 1214 17659 16445 0 0 0 0 0 X false false false X 101622 85122 631438 356136 442190 1616508 0 0 0 0 0 0 0 0 0 0 0 0 101622 85122 631438 356136 442190 1616508 1616508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1616508 1 0.8105 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Part VI, Section B, Line 1 Section A Line 1a: The organization has board members with voting rights. The designation of board members the manner of election qualifications and rights of such members are outlined in the organizational bylaws. Part VI, Line 2 Zaven Khachaturian and Ara Khachaturian have a family and business relationship Part VI, Line 11b The organization ensures compliance with applicable regulations regarding the review and distribution of Form 990. In 2023 a copy of the Form 990 was provided to all voting members via secure electronic method. Part VI, Line 12c The purpose of the conflict of interest policy is to protect this tax-exempt organizations interest when it is contemplating entering into a transaction or arrangement that might benefit the private interest of an officer or director of the Organization or might result in a possible excess benefit transaction. This policy is intended to supplement but not replace any applicable state and federal laws governing conflict of interest applicable to nonprofit and charitable organizations. The organization requires all members and volunteers on an annual basis to provide a conflict of interest statement as provided by the ICMJE website or other relevant information to disclose both relevant financial and intellectual conflicts of interest. Part VI, Line 19 These documents are available upon request.